Lv41
500 积分 2023-08-07 加入
Final overall survival analysis and exploratory biomarker study from JUPITER-06: a randomized phase III trial of toripalimab plus chemotherapy in advanced esophageal squamous-cell carcinoma
1小时前
待确认
Mapping the functional network of human cancer through machine learning and pan-cancer proteogenomics
2小时前
待确认
PERCEPTION predicts patient response and resistance to treatment using single-cell transcriptomics of their tumors
2小时前
待确认
Prediction of drug efficacy from transcriptional profiles with deep learning
2小时前
待确认
Deep learning enables rapid identification of potent DDR1 kinase inhibitors
2小时前
待确认
Discovery of novel antitumor sulfonamides targeting G1 phase of the cell cycle
3小时前
待确认
Discovery and characterization of YSA64, a RBM39 degrader with in vivo efficacy and potent cellular activity in pediatric Ewing sarcoma A673
3小时前
待确认
Structural basis of indisulam-mediated RBM39 recruitment to DCAF15 E3 ligase complex
3小时前
待确认
Structural complementarity facilitates E7820-mediated degradation of RBM39 by DCAF15
3小时前
待确认
Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study
3小时前
待确认
皖公网安备34019202002308
